The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNNN.L Regulatory News (NNN)

  • There is currently no data for NNN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Subscription to raise £0.4 million

10 Jan 2023 07:00

RNS Number : 1628M
Nanosynth Group PLC
10 January 2023
 

 

 

10th January 2023

 

nanosynth group plc

("nanosynth" or the "Company" or the "Group")

Placing and Subscription to raise £0.4 million

nanosynth group plc, the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, is pleased to announce a conditional placing to raise gross proceeds of £0.4 million (the "Placing") through the issue of 222,222,222 new ordinary shares of 0.01 pence each in the Company ("Ordinary Shares") at a price of 0.18 pence per Ordinary Share (the "Placing Shares").

The issue of the Placing Shares is within the Company's existing allotment authorities. The Placing Shares equate to approximately 8.4% of the Company's currently issued share capital. In addition, participants in the Placing have been issued with one warrant for every two Placing Shares exercisable at 0.5p pence per share at any time up to two years from Admission, as defined below.

The funds raised from the Placing will be principally used for working capital purposes and to accelerate the Company's near-term commercial opportunities.

Mark Duffin, CEO of nanosynth, commented: "I am pleased that we are able to raise money to further our commercial objectives. We are receiving considerable interest from major household brands for our nanoparticle technology and these funds will enable the Company to advance the progress of these discussions. We look forward to updating the market on these developments shortly."

Admission and Total Voting Rights

The Placing has been conducted utilising the Company's existing share issuance authorities. The Placing Shares will rank pari passu in all respects with the existing Ordinary Shares. The Placing is conditional, inter alia, on there being no breach of the obligations under the Placing Agreement entered into between Monecor (London) Ltd (trading as OvalX) and the Company prior to Admission, and admission of the Placing Shares to trading on the AIM Market of the London Stock Exchange ("Admission") becoming effective. Application will be made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM. It is expected that Admission will become effective and that dealings in the Placing Shares on the London Stock Exchange will commence on or around 16th January 2023.

On Admission, the Company will have 2,873,744,208 Ordinary Shares in issue, each with one voting right. There are no Ordinary Shares held in treasury. Therefore, the Company's total number of voting rights will be 2,873,744,208 and this figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

nanosynth group plc

Mark Duffin, CEO

Via IFC

 

SP Angel Corporate Finance LLP

Stuart Gledhill

Kasia Brzozowska

 

 

+44 (0)20 3470 0470

 

IFC Advisory Limited

Graham Herring

Zach Cohen

 

+44 20 (0) 3934 6630

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFKLLBXFLBBBL
Date   Source Headline
17th Nov 20237:00 amRNSCancellation - Nanosynth Group PLC
14th Nov 20234:10 pmRNSCompany Insolvency
29th Sep 20237:00 amRNSAccounts Update
30th Aug 20233:30 pmRNSAppointment of Joint Broker
30th Aug 20237:00 amRNSResignation of Finance Director
28th Jul 20233:53 pmRNSResignation of Chief Executive Officer
26th Jun 202311:24 amRNSAccounts Update
14th Jun 20233:27 pmRNSNotice re. General Meeting
24th May 20232:27 pmRNSNotice of General Meeting
16th May 202312:28 pmRNSProposal to Appoint Liquidators
16th May 202312:03 pmRNSSuspension - Nanosynth Group plc
28th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20233:05 pmRNSFinancial Position
31st Jan 20237:00 amRNSTotal Voting Rights
26th Jan 20233:42 pmRNSDirectorate Change
20th Jan 202310:48 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSCorporate and Commercial Update
10th Jan 20237:00 amRNSPlacing and Subscription to raise £0.4 million
4th Jan 20232:56 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Report
6th Sep 20224:47 pmRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20222:05 pmRNSSecond Price Monitoring Extn
31st Aug 20222:00 pmRNSPrice Monitoring Extension
31st Aug 202211:05 amRNSSecond Price Monitoring Extn
31st Aug 202211:00 amRNSPrice Monitoring Extension
31st Aug 20229:05 amRNSSecond Price Monitoring Extn
31st Aug 20229:00 amRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSSuccessful Trial Results
30th Aug 20227:00 amRNSJoint Development Agreement in Cosmetics Market
26th Aug 20227:00 amRNSLanstead Subscription and Sharing Agreement
1st Aug 20222:05 pmRNSSecond Price Monitoring Extn
1st Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20221:08 pmRNSPDMR Dealings
26th Jul 20222:41 pmRNSResult of AGM
12th Jul 202211:06 amRNSSecond Price Monitoring Extn
12th Jul 202211:00 amRNSPrice Monitoring Extension
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
11th Jul 20224:40 pmRNSSecond Price Monitoring Extn
11th Jul 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
11th Jul 202210:30 amRNSDirector/PDMR dealings
6th Jul 20229:00 amRNSPrice Monitoring Extension
5th Jul 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.